ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025

Targeted protein degradation with bifunctional molecules as a novel therapeutic modality for Alzheimer's disease & beyond.

C Alexander Sandhof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.